Asia Pacific Structural Heart Market Forecast to 2028
Asia Pacific Structural Heart Market Forecast to 2028 – Regional Analysis – by Product (Occluders, Annuloplasty Rings, Heart Valve Balloons, and Others), Procedure (Heart Valve Stenosis, Heart Valve Regurgitation, and Left Atrial Appendage Closure), and End User (Hospitals, Ambulatory Surgical Centers, and Cardiac Centers)
$2,100 – $3,500
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Technological Advancements in the Field of Structural Heart Devices Fuel Asia Pacific Structural Heart Market
Transcatheter procedures lead to improvements in patients’ heart conditions in shorter a period compared to surgical intervention. In addition, minimally invasive procedures have reduced surgical and cardiopulmonary risks, which results in increased patient satisfaction. TAVR has gathered more attention due to its ability to offer a reasonable option for the treatment of degenerative aortic stenosis. In 2017, the Edwards Lifesciences’s Edwards Sapien valve was under the studies in the PARTNER trial. The valve has been made from a bovine pericardial tissue valve, and it is sutured on a cobalt-chromium stent scaffold. The stent allows the maximum possible folding of the valve, which allows to maintain the structural and radial support once it is expanded. Moreover, the recent developments in structural heart devices focus on indications, and results of left atrial appendage (LAA) and patent foramen ovale (PFO) closure to prevent cardioembolic stroke. A few of the technological advancements by the players in the Asia Pacific Structural Heart Market are mentioned. In February 2023, Medtronic announced the relaunch of its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired RVOT. Evolut FX added new features to the existing Evolut platform to enhance ease of use and predictable valve deployment for physicians. In May 2022, Philips launched EchoNavigator 4.0, the new release of its image-guided therapy solution, for the treatment of structural heart disease. EchoNavigator 4.0 provides the users of Philips’ EPIQ CVXi interventional cardiology ultrasound system a control of live fusion-imaging on the company’s Image Guided Therapy System called “Azurion – platform.” In September 2021, Abbott received FDA approval for its Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease. With this new device, Abbott expanded its Epic surgical valve platform. In August 2021, CORCYM enrolled the first patient in the Mitral, Aortic, and Tricuspid Post-Market Study in a Real-World Setting, i.e., MANTRA. The first implantation was performed at Citta di Lecce Hospital in Italy with a Bicarbon aortic mechanical valve. In August 2021, the first Made in India 3D printed heart valve was developed in Chennai. The new heart valves were developed using 3D printers, which could overcome the problems related to artificial heart valves. Therefore, technological advancements are leading to new growth trends in the Asia Pacific Structural Heart Market growth.
Asia Pacific Structural Heart Market Overview
The Asia Pacific structural heart market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The region holds a significant market share in the global structural heart market. The Asia Pacific structural heart market is expected to witness significant growth during the forecast period due to factors such as the significant growth in elderly population, growing cardiovascular diseases, and launch of innovative products by market players in the region.
Asia Pacific Structural Heart Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Structural Heart Market Segmentation
The Asia Pacific structural heart market is segmented into product, procedure, end user, and country.
Based on product, the Asia Pacific structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest share of the Asia Pacific structural heart market in 2022.
Based on procedure, the Asia Pacific structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held the largest share of the Asia Pacific structural heart market in 2022.
Based on end user, the Asia Pacific structural heart market is segmented into hospitals, ambulatory surgical centres, and others. The hospitals segment held the largest share of the Asia Pacific structural heart market in 2022.
Based on country, the Asia Pacific structural heart market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific structural heart market in 2022.
Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, Edwards Lifesciences Corp, and Lepu Medical Technology Beijing Co Ltd are some of the leading companies operating in the Asia Pacific structural heart market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Publishing status: | |
| Geographical coverage: | |
| Year of Publication: |
According to Business Market Insights research, the Asia Pacific structural heart market was valued at US$ 2,649.67 million in 2022 and is expected to reach US$ 4,374.55 million by 2028, registering a CAGR of 8.7% from 2022 to 2028. Availability of innovative structural heart services and rise in the number of cardiovascular diseases and training programs are the factors attributed to the Asia Pacific structural heart market expansion.
The number of interventional structural heart disease (SHD) procedures, such as transcatheter valve procedures, has increased significantly in recent years, triggering the need for well-founded knowledge about optimal anatomical spatial orientation during these procedures. This has led to the development of new procedural capabilities and technologies in periprocedural planning. Hybrid fusion imaging (FI) combines multiple imaging modalities, mainly based on multislice spiral computed tomography (MSCT) and echocardiography, with fluoroscopy. Ongoing developments in machine learning and artificial intelligence (AI) facilitate the routine use of individualized segmented 3D heart models that allow for multiple combinations of different imaging modalities. As AI enables computers to perform tasks at a greater speed and with potentially better precision than humans, risk stratification and outcome aspects can be optimized in the future. The application of computer modeling, 3D printing, and AI has already led to transformations in procedure planning and physician education on SHD. These technologies also promise unlimited possibilities. With further research and development, AI can advance precision medicine at every step, including diagnosis, treatment stratification and device selection, procedure delivery and guidance, and post-procedure/discharge monitoring and rehabilitation. The prevalence of cardiovascular diseases is rising in the country. For instance, in India, KIMS hospital provides services for the structural heart in the south Indian region. Most of the people in this region chew or smoke tobacco, and the incidence of structural heart disease is increasing in this region. South and Southeast Asia also reported higher mortality rates. Thus, with the rising incidence of structural heart diseases in the abovementioned regions, the market players are likely to grab significant opportunities to offer effective products.
On the contrary, high cost of procedures systems hampers the Asia Pacific structural heart market.
Based on product, the Asia Pacific structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held 40.3% share of Asia Pacific structural heart market in 2022, amassing US$ 1,067.15 million. It is projected to garner US$ 1,787.33 million by 2028 to expand at 9.0% CAGR during 2022-2028.
Based on procedure, the Asia Pacific structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held 45.7% share of Asia Pacific structural heart market in 2022, amassing US$ 1,210.82 million. It is projected to garner US$ 2,058.26 million by 2028 to expand at 9.2% CAGR during 2022-2028.
Based on end user, the Asia Pacific structural heart market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held 49.2% share of Asia Pacific structural heart market in 2022, amassing US$ 1,302.42 million. It is projected to garner US$ 2,201.03 million by 2028 to expand at 9.1% CAGR during 2022-2028.
Based on country, the Asia Pacific structural heart market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 28.8% share of Asia Pacific structural heart market in 2022. It was assessed at US$ 762.05 million in 2022 and is likely to hit US$ 1,296.18 million by 2028, exhibiting a CAGR of 9.3% during 2022-2028.
Key players operating in the Asia Pacific structural heart market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, Edwards Lifesciences Corp, and Lepu Medical Technology Beijing Co Ltd, among others.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific structural heart market.
o Highlights key business priorities to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific structural heart market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Research Team Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Structural Heart Market – by Product
1.3.2 Asia Pacific Structural Heart Market – by Procedure
1.3.3 Asia Pacific Structural Heart Market – by End User
1.3.4 Asia Pacific Structural Heart Market – by Country
2. Asia Pacific Structural Heart Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Structural Heart Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
4.3 Expert’s Opinion
5. Asia Pacific Structural Heart Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Availability of Innovative Structural Heart Services
5.1.2 Rising Number of Cardiovascular Disease Cases and Training Programs
5.2 Key Market Restraints
5.2.1 High Cost of Procedures
5.2.2 Stringent Regulations Regarding Structure Heart Devices
5.3 Key Market Opportunities
5.3.1 Growing Use of Artificial Intelligence in Structural Heart
5.4 Future Trends
5.4.1 Technological Advancements in the Field of Structural Heart Devices
5.5 Impact analysis
6. Structural Heart Market -Asia Pacific Analysis
6.1 Asia Pacific Structural Heart Market Revenue Forecast and Analysis
7. Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 – by Product
7.1 Overview
7.2 Asia Pacific Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
7.3 Occluders
7.3.1 Overview
7.3.2 Occluders: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Annuloplasty Rings
7.4.1 Overview
7.4.2 Annuloplasty Rings: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Heart Valve Balloons
7.5.1 Overview
7.5.2 Heart Valve Balloons: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 – by Procedure
8.1 Overview
8.2 Asia Pacific Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
8.3 Heart Valve Stenosis
8.3.1 Overview
8.3.2 Heart Valve Stenosis: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Heart Valve Regurgitation
8.4.1 Overview
8.4.2 Heart Valve Regurgitation: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Left Atrial Appendage Closure
8.5.1 Overview
8.5.2 Left Atrial Appendage Closure: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 – by End User
9.1 Overview
9.2 Asia Pacific Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiac Centers
9.5.1 Overview
9.5.2 Cardiac Centers: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 -Country Analysis
10.1 Asia Pacific: Asia Pacific Structural Heart Market
10.1.1 Overview
10.1.2 Asia Pacific: Asia Pacific Structural Heart Market, by Country, 2021 & 2028 (%)
10.1.2.1 China: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 China: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 China: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
10.1.2.1.4 China: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
10.1.2.1.4.1 China: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
10.1.2.1.4.2 China: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
10.1.2.1.5 China: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
10.1.2.2 Japan: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Japan: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Japan: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
10.1.2.2.4 Japan: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
10.1.2.2.4.1 Japan: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
10.1.2.2.4.2 Japan: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
10.1.2.2.5 Japan: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
10.1.2.3 India: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 India: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 India: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
10.1.2.3.4 India: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
10.1.2.3.4.1 India: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
10.1.2.3.4.2 India: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
10.1.2.3.5 India: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
10.1.2.4 Australia: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 Australia: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.3 Australia: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
10.1.2.4.4 Australia: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
10.1.2.4.4.1 Australia: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
10.1.2.4.4.2 Australia: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
10.1.2.4.5 Australia: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
10.1.2.5 South Korea: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 South Korea: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.3 South Korea: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
10.1.2.5.4 South Korea: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
10.1.2.5.4.1 South Korea: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
10.1.2.5.4.2 South Korea: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
10.1.2.5.5 South Korea: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
10.1.2.6 Rest of Asia Pacific: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.3 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
10.1.2.6.4 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
10.1.2.6.4.1 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
10.1.2.6.4.2 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
10.1.2.6.5 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
11. Asia Pacific Structural Heart Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies
11.2.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Artivion Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Edwards Lifesciences Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Micro Interventional Devices Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. China Asia Pacific Structural Heart Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. China Asia Pacific Structural Heart Market, by Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 3. China Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 4. China Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 5. China Asia Pacific Structural Heart Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan Asia Pacific Structural Heart Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan Asia Pacific Structural Heart Market, by Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 8. Japan Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 9. Japan Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 10. Japan Asia Pacific Structural Heart Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. India Asia Pacific Structural Heart Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 12. India Asia Pacific Structural Heart Market, by Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 13. India Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 14. India Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 15. India Asia Pacific Structural Heart Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Australia Asia Pacific Structural Heart Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 17. Australia Asia Pacific Structural Heart Market, by Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 18. Australia Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 19. Australia Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 20. Australia Asia Pacific Structural Heart Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. South Korea Asia Pacific Structural Heart Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 22. South Korea Asia Pacific Structural Heart Market, by Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 23. South Korea Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 24. South Korea Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 25. South Korea Asia Pacific Structural Heart Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Rest of Asia Pacific Structural Heart Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 27. Rest of Asia Pacific Structural Heart Market, by Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 28. Rest of Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 29. Rest of Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure – Revenue and Forecast to 2028 (US$ Million)
Table 30. Rest of Asia Pacific Structural Heart Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. Recent Organic Growth Strategies in Asia Pacific Structural Heart Market
Table 32. Glossary of Terms
LIST OF FIGURES
Figure 1. Asia Pacific Structural Heart Market Segmentation
Figure 2. Asia Pacific Structural Heart Market, by Country
Figure 3. Asia Pacific Structural Heart Market Overview
Figure 4. Occluders Segment Held Largest Share of Product Segment in Asia Pacific Structural Heart Market
Figure 5. Asia Pacific: PEST Analysis
Figure 6. Asia Pacific Structural Heart Market Experts’ Opinion
Figure 7. Asia Pacific Structural Heart Market: Impact Analysis of Drivers and Restraints
Figure 8. Asia Pacific Structural Heart Market – Revenue Forecast and Analysis – 2019-2028
Figure 9. Asia Pacific Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
Figure 10. Occluders: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Annuloplasty Rings: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Heart Valve Balloons: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Asia Pacific Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
Figure 15. Heart Valve Stenosis: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Heart Valve Regurgitation: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Left Atrial Appendage Closure: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Asia Pacific Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
Figure 19. Hospitals: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ambulatory Surgical Centers: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Cardiac Centers: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Asia Pacific Structural Heart Market, by Key Country – Revenue (2021) (US$ Million)
Figure 23. Asia Pacific: Asia Pacific Structural Heart Market, by Country, 2021 & 2028 (%)
Figure 24. China: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Japan: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. India: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Australia: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. South Korea: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Rest of Asia Pacific: Asia Pacific Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
The List of Companies – Asia Pacific Structural Heart Market
o Abbott Laboratories
o Medtronic Plc
o Boston Scientific Corp
o Artivion Inc
o Edwards Lifesciences Corp
o Lepu Medical Technology Beijing Co Ltd
You must be logged in to post a review.
Reviews
There are no reviews yet.